For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Practices’ extra dose of inflation
Wednesday 11 May 2022, 01:50 AM

There’s national inflation and then there is inflation for general practices [Image: alexsl on iStock]
GENPRO
Inflation specific to general practice is far outstripping that of the Consumer Price Index, writes Tim Malloy, who posits a GP boycott of some services if the Budget doesn’t sort this
A funding increase of 2.78 per cent does not cover cost pressure increases of between 14 and 17 per cent
It’s the Government’s Budget month, and
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.